default author photo

Bethany Torr

Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology

London

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

244

TOTAL CITATIONS

6

Scholarly Papers (2)

1.

Collateral Damage: The Impact on Cancer Outcomes of the COVID-19 Pandemic

Number of pages: 29 Posted: 20 May 2020
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Royal Marsden NHS Foundation Trust - Urology Unit, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust - Department of Colorectal Surgery, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Lung Cancer Unit, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Department of Clinical Oncology, Royal Marsden NHS Foundation Trust - RM Partners, University of Cambridge - Department of Public Health and Primary Care, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Imperial College Healthcare NHS Trust - Department of Clinical Oncology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 171 (440,151)
Citation 6

Abstract:

Loading...

cancer; diagnosis; surgery; COVID-19 pandemic; diagnostic delay; healthcare resource; life years gained; survival

2.

Quantifying and Mitigating the Impact of the COVID-19 Pandemic on Outcomes in Colorectal Cancer

Number of pages: 25 Posted: 08 Jun 2020
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Public Health England - National Cancer Registration and Analysis Service, West London Cancer Alliance - RM Partners, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Royal Marsden NHS Foundation Trust - Urology Unit, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust - Department of Colorectal Surgery, Imperial College Healthcare NHS Trust - Department of Clinical Oncology, Public Health England - National Cancer Registration and Analysis Service, West London Cancer Alliance - RM Partners, Imperial College London - School of Public Health, West London Cancer Alliance - RM Partners, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Imperial College London - School of Public Health, NHS Foundation Trust - Croydon University Hospital, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 73 (852,604)

Abstract:

Loading...

COVID-19; Oncology; Colonoscopy; Endoscopy; Fecal Immunochemical Test; FIT; Bowel; Colorectal; Cancer; Pandemic; delay in treatment